# Marcus Corp: financial statements, quarterly

MCS · NYSE · CIK 62234 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mcs.md) · [Financials](/companies/mcs/financials.md) · [Filings](/companies/mcs/filings.md) · [Insiders](/companies/mcs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mcs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-28) | Q4 FY2023 (2023-12-28) | Q1 FY2024 (2024-03-28) | Q2 FY2024 (2024-06-27) | Q3 FY2024 (2024-09-26) | Q4 FY2024 (2024-12-26) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [209](/filings/0000062234-24-000055.md) | [162 d](/filings/0000062234-26-000011.md) | [139](/filings/0000062234-25-000026.md) | [176](/filings/0000062234-25-000037.md) | [233](/filings/0000062234-25-000047.md) | [188 d](/filings/0000062234-26-000011.md) | [149](/filings/0000062234-26-000028.md) | [206](/filings/0000062234-26-000041.md) | [210](/filings/0000062234-25-000047.md) | [193 d](/filings/0000062234-26-000011.md) | [154](/filings/0000062234-26-000028.md) | [232](/filings/0000062234-26-000041.md) |
| Operating income | $m | [20.9](/filings/0000062234-24-000055.md) | [1.2 d](/filings/0000062234-26-000011.md) | [(16.7)](/filings/0000062234-25-000026.md) | [2.2](/filings/0000062234-25-000037.md) | [32.8](/filings/0000062234-25-000047.md) | [(2.2) d](/filings/0000062234-26-000011.md) | [(20.4)](/filings/0000062234-26-000028.md) | [13.0](/filings/0000062234-26-000041.md) | [22.7](/filings/0000062234-25-000047.md) | [1.7 d](/filings/0000062234-26-000011.md) | [(19.3)](/filings/0000062234-26-000028.md) | [27.1](/filings/0000062234-26-000041.md) |
| Interest expense | $m | [2.9](/filings/0000062234-23-000055.md) | [3.8 d](/filings/0000062234-24-000011.md) | [2.5](/filings/0000062234-24-000028.md) | [2.6](/filings/0000062234-25-000037.md) | [3.1](/filings/0000062234-25-000047.md) | [2.8 d](/filings/0000062234-26-000011.md) | [2.8](/filings/0000062234-26-000028.md) | [3.0](/filings/0000062234-26-000041.md) | [2.8](/filings/0000062234-25-000047.md) | [2.9 d](/filings/0000062234-26-000011.md) | [2.6](/filings/0000062234-26-000028.md) | [2.7](/filings/0000062234-26-000041.md) |
| Income tax | $m | [5.9](/filings/0000062234-24-000055.md) | [(0.3) d](/filings/0000062234-26-000011.md) | [(7.4)](/filings/0000062234-25-000026.md) | [5.7](/filings/0000062234-25-000037.md) | [5.4](/filings/0000062234-25-000047.md) | [(6.2) d](/filings/0000062234-26-000011.md) | [(7.4)](/filings/0000062234-26-000028.md) | [2.7](/filings/0000062234-26-000041.md) | [8.0](/filings/0000062234-25-000047.md) | [(7.3) d](/filings/0000062234-26-000011.md) | [(7.6)](/filings/0000062234-26-000028.md) | [8.1](/filings/0000062234-26-000041.md) |
| Net income | $m | [12.2](/filings/0000062234-24-000055.md) | [(1.4) d](/filings/0000062234-26-000011.md) | [(11.9)](/filings/0000062234-25-000026.md) | [(20.2)](/filings/0000062234-25-000037.md) | [23.3](/filings/0000062234-25-000047.md) | [1.0 d](/filings/0000062234-26-000011.md) | [(16.8)](/filings/0000062234-26-000028.md) | [7.3](/filings/0000062234-26-000041.md) | [16.2](/filings/0000062234-25-000047.md) | [6.0 d](/filings/0000062234-26-000011.md) | [(15.4)](/filings/0000062234-26-000028.md) | [15.8](/filings/0000062234-26-000041.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-28) | FY2023 (2023-12-28) | Q1 FY2024 (2024-03-28) | Q2 FY2024 (2024-06-27) | Q3 FY2024 (2024-09-26) | FY2024 (2024-12-26) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [36.0](/filings/0000062234-23-000055.md) | [55.6](/filings/0000062234-25-000006.md) | [17.3](/filings/0000062234-24-000028.md) | [32.8](/filings/0000062234-24-000047.md) | [28.4](/filings/0000062234-24-000055.md) | [40.8](/filings/0000062234-26-000011.md) | [11.9](/filings/0000062234-25-000026.md) | [14.9](/filings/0000062234-25-000037.md) | [7.4](/filings/0000062234-25-000047.md) | [23.4](/filings/0000062234-26-000041.md) | [11.2](/filings/0000062234-26-000028.md) | [26.3](/filings/0000062234-26-000041.md) |
| Current assets | $m | [86.1](/filings/0000062234-23-000055.md) | [102](/filings/0000062234-25-000006.md) | [61.5](/filings/0000062234-24-000028.md) | [90.7](/filings/0000062234-24-000047.md) | [87.7](/filings/0000062234-24-000055.md) | [92.2](/filings/0000062234-26-000011.md) | [59.8](/filings/0000062234-25-000026.md) | [61.0](/filings/0000062234-25-000037.md) | [50.7](/filings/0000062234-25-000047.md) | [64.6](/filings/0000062234-26-000041.md) | [50.4](/filings/0000062234-26-000028.md) | [71.7](/filings/0000062234-26-000041.md) |
| Total assets | $m | [1,054](/filings/0000062234-23-000055.md) | [1,065](/filings/0000062234-26-000011.md) | [1,018](/filings/0000062234-25-000026.md) | [1,052](/filings/0000062234-25-000037.md) | [1,047](/filings/0000062234-25-000047.md) | [1,045](/filings/0000062234-26-000011.md) | [1,018](/filings/0000062234-26-000028.md) | [1,016](/filings/0000062234-26-000041.md) | [1,004](/filings/0000062234-25-000047.md) | [1,015](/filings/0000062234-26-000041.md) | [992](/filings/0000062234-26-000028.md) | [1,000](/filings/0000062234-26-000041.md) |
| Current liabilities | $m | [147](/filings/0000062234-23-000055.md) | [164](/filings/0000062234-25-000006.md) | [142](/filings/0000062234-24-000028.md) | [179](/filings/0000062234-24-000047.md) | [161](/filings/0000062234-24-000055.md) | [177](/filings/0000062234-26-000011.md) | [143](/filings/0000062234-25-000026.md) | [157](/filings/0000062234-25-000037.md) | [144](/filings/0000062234-25-000047.md) | [163](/filings/0000062234-26-000041.md) | [145](/filings/0000062234-26-000028.md) | [165](/filings/0000062234-26-000041.md) |
| Long-term debt | $m | [160](/filings/0000062234-23-000055.md) | [160](/filings/0000062234-25-000006.md) | [160](/filings/0000062234-24-000028.md) | [165](/filings/0000062234-24-000047.md) | [163](/filings/0000062234-24-000055.md) | [149](/filings/0000062234-26-000011.md) | [189](/filings/0000062234-25-000026.md) | [170](/filings/0000062234-25-000037.md) | [162](/filings/0000062234-25-000047.md) | [159](/filings/0000062234-26-000041.md) | [174](/filings/0000062234-26-000028.md) | [149](/filings/0000062234-26-000041.md) |
| Current portion of debt | $m | [10.4](/filings/0000062234-23-000055.md) | [10.3](/filings/0000062234-25-000006.md) | [10.3](/filings/0000062234-24-000028.md) | [10.8](/filings/0000062234-24-000047.md) | [10.5](/filings/0000062234-24-000055.md) | [10.1](/filings/0000062234-26-000011.md) | [9.8](/filings/0000062234-25-000026.md) | [9.8](/filings/0000062234-25-000037.md) | [0.0](/filings/0000062234-25-000047.md) | [0.0](/filings/0000062234-26-000011.md) | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [473](/filings/0000062234-23-000055.md) | [471](/filings/0000062234-25-000006.md) | [459](/filings/0000062234-24-000028.md) | [449](/filings/0000062234-24-000047.md) | [462](/filings/0000062234-24-000055.md) | [465](/filings/0000062234-26-000011.md) | [442](/filings/0000062234-25-000026.md) | [448](/filings/0000062234-25-000037.md) | [454](/filings/0000062234-25-000047.md) | [457](/filings/0000062234-26-000041.md) | [441](/filings/0000062234-26-000028.md) | [457](/filings/0000062234-26-000041.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-28) | Q4 FY2023 (2023-12-28) | Q1 FY2024 (2024-03-28) | Q2 FY2024 (2024-06-27) | Q3 FY2024 (2024-09-26) | Q4 FY2024 (2024-12-26) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [21.3 d](/filings/0000062234-24-000055.md) | [34.0 d](/filings/0000062234-26-000011.md) | [(15.1)](/filings/0000062234-25-000026.md) | [36.0 d](/filings/0000062234-25-000037.md) | [30.5 d](/filings/0000062234-25-000047.md) | [52.6 d](/filings/0000062234-26-000011.md) | [(35.3)](/filings/0000062234-26-000028.md) | [31.6 d](/filings/0000062234-26-000041.md) | [39.1 d](/filings/0000062234-25-000047.md) | [48.8 d](/filings/0000062234-26-000011.md) | [(15.2)](/filings/0000062234-26-000028.md) | [54.0 d](/filings/0000062234-26-000041.md) |
| Capital expenditure | $m | [9.9 d](/filings/0000062234-24-000055.md) | [12.9 d](/filings/0000062234-26-000011.md) | [15.4](/filings/0000062234-25-000026.md) | [19.8 d](/filings/0000062234-25-000037.md) | [18.5 d](/filings/0000062234-25-000047.md) | [25.4 d](/filings/0000062234-26-000011.md) | [23.0](/filings/0000062234-26-000028.md) | [16.9 d](/filings/0000062234-26-000041.md) | [20.9 d](/filings/0000062234-25-000047.md) | [22.4 d](/filings/0000062234-26-000011.md) | [6.6](/filings/0000062234-26-000028.md) | [10.0 d](/filings/0000062234-26-000041.md) |
| Dividends paid | $m | [2.2 d](/filings/0000062234-24-000055.md) | [2.2 d](/filings/0000062234-26-000011.md) | [2.2](/filings/0000062234-25-000026.md) | [2.2 d](/filings/0000062234-25-000037.md) | [2.2 d](/filings/0000062234-25-000047.md) | [2.2 d](/filings/0000062234-26-000011.md) | [2.2](/filings/0000062234-26-000028.md) | [2.1 d](/filings/0000062234-26-000041.md) | [2.4 d](/filings/0000062234-25-000047.md) | [2.4 d](/filings/0000062234-26-000011.md) | [2.4](/filings/0000062234-26-000028.md) | [2.4 d](/filings/0000062234-26-000041.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-29) | Q1 FY2023 (2023-03-30) | Q2 FY2023 (2023-06-29) | Q3 FY2023 (2023-09-28) | Q1 FY2024 (2024-03-28) | Q2 FY2024 (2024-06-27) | Q3 FY2024 (2024-09-26) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [40.7](/filings/0000062234-23-000055.md) | [31.6](/filings/0000062234-24-000028.md) | [40.9](/filings/0000062234-24-000047.md) | [41.0](/filings/0000062234-24-000055.md) | [31.9](/filings/0000062234-25-000026.md) | [32.2](/filings/0000062234-25-000037.md) | [32.0](/filings/0000062234-25-000047.md) | [31.6](/filings/0000062234-26-000028.md) | [31.4](/filings/0000062234-26-000041.md) | [31.2](/filings/0000062234-25-000047.md) | [30.7](/filings/0000062234-26-000028.md) | [31.0](/filings/0000062234-26-000041.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 19,023,386 at 2017-02-28, from the cover of the [10-K filed 2017-03-14](/filings/0001144204-17-014538.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.